People

Bridging the Gap from Acute Stroke to Brain Stewardship The Mission I am a vascular neurologist and researcher dedicated to a single, urgent goal: ensuring that a stroke survivor’s journey does not end with "survival," but continues into a life of neurological health and cognitive resilience. Over the past two decades, my work has spanned the globe—from India and Europe to my current home at Yale School of Medicine and the West Haven VA. A Legacy of Impact My early research focused on breaking down unnecessary barriers to acute care. I led the pivotal studies (published in The BMJ and Neurology) that challenged age-based and several other exclusions for thrombolysis, findings that were eventually integrated into the AHA/ASA National Stroke Guidelines. Today, my scholarly work is cited nearly 3,000 times, serving as a foundation for evidence-based stroke protocols worldwide. The Current Frontier: IPSERC and Brain Recovery At Yale, I have pivoted to the "next frontier" of stroke: long-term recovery. Preventing Epilepsy: I co-founded and lead the International Post Stroke Epilepsy Research Consortium (IPSERC). Our recent leadership in JAMA Neurology and Stroke is uncovering the genomic and clinical "signatures" that predict post-stroke seizures, moving us closer to the first generation of preventative anti-epileptogenic therapies. As a stroke specialist, my service on the American Epilepsy Society Scientific Program Committee serves as a strategic bridge for interdisciplinary scholarship. In this role, I lead the development of scientific programming that integrates stroke and epilepsy research, directly advancing my primary research agenda in post-stroke epilepsy.Cognitive Resilience: I am investigating how cultural and linguistic assets, such as bilingualism, act as a "cognitive reserve" that shields the brain from post-stroke decline. My vision is to develop cost-effective, community-based interventions that protect the cognitive identity of every patient. For Future Collaborators and Trainees I am a "traditional" neurologist at heart. Whether at the bedside at the VA or in the teachin session at Yale, I believe in the power of clinical storytelling and meticulous semiology. To Trainees: My lab is a global pipeline. I have had the privilege of mentoring students who have won AAN awards, matched into top-tier residencies, and serving as professor internationally. I provide a mentorship experience that balances high-level scientific rigor with personalized professional growth.To Collaborators: I believe in "convening power." Through IPSERC (co-convened with Patrick Kwan, MD, Monash University), I foster an environment where multidisciplinary experts from genomics, neurology, and neuro-critical care work together to solve the field’s most complex recovery challenges. Vision for the Future I am working toward a world where post-stroke epilepsy is preventable and where a patient's cultural background is leveraged as a medical tool for recovery. I invite you to join me in this mission to protect the brain, one patient and one discovery at a time. Email: nishant.mishra@yale.edu ==================================================================== Statement of Research, Leadership, and International Standing OverviewFor over 20 years, my career has been defined by a commitment to transforming the management of stroke and its long-term complications. My trajectory represents a transition from a skilled clinician identifying complex neurological syndromes to an internationally recognized architect of global research infrastructure. Today, my work at the intersection of Big Data, genomics, and clinical policy directly shapes the international standards of care for stroke and post-stroke epilepsy. Clinical Foundation and Practice-Changing Research (2005–2015): My early career was dedicated to expanding the boundaries of acute stroke treatment. Through landmark first-author publications in The BMJ and Stroke, I led the pivotal studies that proved the safety and efficacy of thrombolysis in traditionally "excluded" populations, most notably the very elderly and those with prior stroke and diabetes. This body of work provided the definitive evidence base for the AHA/ASA, Japanese, and European clinical guidelines, effectively expanding life-saving treatment eligibility to millions of high-risk patients worldwide. Global Leadership and Infrastructure Building (2016–Present): Recognizing that the next frontier of stroke care lies in long-term outcomes, I founded the International Post Stroke Epilepsy Research Consortium (IPSERC). As the senior architect of the IPSERR repository, I currently work on the disparate clinical datasets from across the globe into the world’s most powerful Individual Patient Data (IPD) meta-analysis platform. This leadership has culminated in "gold-standard" evidence published in JAMA Neurology, and Neurology, defining the clinical trajectory and pharmacological management of post-stroke seizures for the modern era. Innovation in Precision Medicine and Federal Impact: My current research program is pioneering the use of genomic risk stratification to predict post-stroke complications. By successfully leveraging the Million Veteran Program (MVP) data, I have secured federal VA funding (co-investigator; Item 55) to develop polygenic risk scores that will allow for personalized, "upstream" prevention of epilepsy. This work, combined with my research on social determinants of health, ensures that my scientific contributions remain rooted in health equity and the specific needs of the veteran population. Mentorship and the Future of the Field: As a faculty member at Yale and with past experience from multiple top world centres, I view my most enduring impact as the success of my trainees. My research team consistently produces high-impact scholarship,, where I serve as senior mentor to the next generation of academic neurologists. By providing these mentees with a seat at the table of international consortia, I am ensuring a sustainable legacy of scientific excellence and global collaboration. Conclusion From my early advocacy for comprehensive stroke programs to my current role leading global data repositories, my career has been dedicated to one goal: improving the lives of stroke survivors through rigorous science and global leadership. I am honored to submit this record as evidence of my sustained contribution to the university, the veteran community, and the international medical field. This is despite several personal losses and hardships along my journey, which have only strengthened my resilience. Scan-Ready Impact Highlights Journal Track Record: Lead or Senior author in The BMJ, JAMA Neurology, Stroke, and Neurology.Policy Influence: Research directly cited in 10+ International Clinical Guidelines (AHA/ASA, UK, Japan, China, Spain, Poland).Federal Funding: Co-Investigator on VA-funded initiatives using Big Data (MVP).Global Architecture: Founder of IPSERC and IPSERR, platforms utilized by researchers worldwide. Education: Summary Statement My academic journey represents a deliberate and rigorous path toward global leadership in stroke neurology. From my PhD at the University of Glasgow to my advanced fellowships at Stanford and UCLA, I have been mentored by the architects of modern stroke therapy. This foundation enabled me to succeed as a clinical neuroscientist across various jurisdictions, secure funding as a co-investigator on a VA project, and lead projects, working closely with the who’s who in the fields of stroke and epileptology. As Stroke Director for the West Haven VA, I bridge the gap between high-level clinical administration and transformative research, ensuring that Yale’s scientific breakthroughs are directly translated into veteran care. ====================================================================

Dr. Misra is a Postdoctoral Associate in the Department of Neurology at Yale University School of Medicine. He is a clinical researcher with an avid interest in biomarker discovery and outcomes research in neurological disorders. He is serving as a member of the COVID-19 global forum in the Brain Health Unit of the World Health Organization. He is also the Guest Editor at Frontiers in Neurology, where he is leading a research collection on omics-based approaches in stroke research. His long-term goal is to become an independent investigator and build a career in clinical biomarker discovery and data sciences. Dr. Misra obtained his Ph.D. in Neurology from the All India Institute of Medical Sciences, New Delhi, India. His thesis was aimed at determining diagnostic and prognostic biomarkers of stroke using high-throughput proteomics and machine learning approaches. He received the prestigious DST-INSPIRE Fellowship from the Department of Science and Technology, Government of India, for pursuing his doctoral studies. He completed his B. Tech and M. Tech degrees in Biotechnology from Amity University, Noida, India, and had the distinction of being the University Gold Medalist. Dr. Misra has co-authored over 50 peer-reviewed research publications, including first-author articles in leading journals such as JAMA Neurology, Neurology, the European Journal of Neurology, and the International Journal of Stroke. His work has been cited more than 1,000 times. He took a 2-hour lecture on "Proteomics data analysis in R" at the peer-to-peer teaching sessions organized by the Bioinformatics Support Hub in the Cushing/Whitney Medical Library at Yale School of Medicine. Dr. Misra is a recipient of the Young Investigator Award from the World Stroke Organization for his contributions to the field of stroke research. He is open to research collaborations on research topics, including: Biomarker research in strokeProteomics data analysisEvidence synthesis through systematic reviews and meta-analysesClinical trials in stroke For research collaborations, reach out to Dr. Misra at shubham.misra@yale.edu. For more details regarding his academic interests, please visit his website at https://sites.google.com/view/shubham-misra.